Larson Financial Group’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.7K Buy
369
+295
+399% +$7.24K ﹤0.01% 2479
2026
Q2
$1.59K Buy
74
+9
+14% +$138 ﹤0.01% 3183
2026
Q1
$902 Sell
65
-146
-69% -$2.33K ﹤0.01% 3189
2025
Q4
$3.43K Buy
211
+141
+201% +$2.3K ﹤0.01% 2612
2025
Q3
$1.05K Buy
+70
New +$853 ﹤0.01% 2908

Other funds holding ADPT

Larson Financial Group's ADPT Position: Q3 2026 in Review

Larson Financial Group increased its Adaptive Biotechnologies (ADPT) stake by 399% in Q3 2026, buying an estimated $7.24K and bringing the position to 369 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2479.

Larson Financial Group first reported a position in ADPT in Q3 2025 and has held it in 5 quarters since. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • Larson Financial Group held 369 shares of Adaptive Biotechnologies worth $10.7K as of Q3 2026.
  • Larson Financial Group bought 295 Adaptive Biotechnologies shares in Q3 2026, an estimated $7.24K.
  • Adaptive Biotechnologies made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2479 holding.
  • Larson Financial Group first reported a position in Adaptive Biotechnologies in Q3 2025 and has held it in 5 quarters since.
  • 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.